Nut consumption in relation to cardiovascular disease risk and type 2 diabetes: a systematic review and meta-analysis of prospective studies
Open accessAbstract
Background Many prospective cohort studies have investigated the association between nut consumption and risk of coronary artery disease (CAD), stroke, hypertension, and type 2 diabetes (T2D). However, results have been inconsistent.Objective We aimed to investigate the association between nut consumption and risk of CAD, stroke, hypertension, and T2D.Design PubMed and EMBASE databases were searched up to October 2013. All prospective cohort studies of nut consumption and risk of CAD, stroke, hypertension, and T2D were included. Summary RRs with 95% CIs were estimated by using a fixed- or random-effects model.Results A total of 23 prospective studies (9 studies for CAD, 4 studies for stroke, 4 studies for hypertension, and 6 studies for T2D) from 19 publications were included in the meta-analysis. There were 179,885 participants and 7236 CAD cases, 182,730 participants and 5669 stroke cases, 40,102 participants and 12,814 hypertension cases, and 342,213 participants and 14,400 T2D cases. The consumption of each 1 serving of nuts/d was significantly associated with incident CAD (RR: 0.81; 95% CI: 0.72, 0.91; P < 0.001) and hypertension (RR: 0.66; 95% CI: 0.44, 1.00; P = 0.049). However, there was no association between the consumption of each 1 serving of nuts/d and risk of stroke (RR: 0.90; 95% CI: 0.71, 1.14) or T2D (RR: 0.80; 95% CI: 0.57, 1.14).Conclusions A higher consumption of nuts was associated with reduced risk of CAD and hypertension but not stroke or T2D. Large randomized controlled trials are warranted to confirm the observed associations.
AI snapshot
Written from the paper’s full text.
TL;DR
This systematic review and meta-analysis of 23 prospective studies found that higher nut consumption was associated with lower risk of coronary artery disease and hypertension, but not stroke or type 2 diabetes. The authors conclude that large randomized controlled trials are needed to confirm these observational associations.
Key findings
- For each 1-serving/d increment in nut consumption, pooled RRs were 0.81 (95% CI: 0.72, 0.91; P < 0.001) for CAD and 0.66 (95% CI: 0.44, 1.00; P = 0.049) for hypertension; no significant associations were found for stroke (RR: 0.90; 95% CI: 0.71, 1.14) or T2D (RR: 0.80; 95% CI: 0.57, 1.14).
- Highest compared with lowest nut intake was inversely associated with CAD (RR: 0.83; 95% CI: 0.74, 0.93) and hypertension (RR: 0.85; 95% CI: 0.79, 0.92), but not stroke (RR: 0.87; 95% CI: 0.74, 1.03) or T2D (RR: 0.92; 95% CI: 0.78, 1.09).
- The meta-analysis included 179,885 participants and 7,236 CAD cases; 182,730 participants and 5,669 stroke cases; 40,102 participants and 12,814 hypertension cases; and 342,213 participants and 14,400 T2D cases.
Methods
- Systematic review and meta-analysis of prospective cohort studies identified from PubMed and EMBASE up to 10 October 2013, including 23 prospective studies from 19 publications.
- Pooled RRs with 95% CIs were estimated using fixed- or random-effects models; dose-response analyses used Greenland et al. and Orsini et al. methods, with restricted cubic splines to test nonlinearity.
- Heterogeneity was assessed with the Q test and I² statistic; meta-regression, sensitivity analyses, and Begg’s and Egger’s tests were used to explore heterogeneity and publication bias; study quality was assessed with the Newcastle-Ottawa scale.
Limitations
- The paper states that observational cohort design cannot rule out unmeasured or residual confounding; most included studies did not provide data on nut types or preparation methods; and most used baseline nut consumption, so dietary changes during follow-up could misclassify exposure.
- The paper also states there was between-study heterogeneity for CAD, stroke, and T2D that meta-regression could not explain, and not all studies adjusted for all covariates such as energy intake, BMI, and age.
- Evident from the text: stroke and hypertension analyses included only 4 cohort studies each, and the authors did not perform stroke subtype subgroup analyses because there were only a few stroke studies; hypertension dose-response analysis had high heterogeneity (I² = 75.9%) and a sensitivity range that included the null (0.67; 95% CI: 0.38, 1.17 to 0.55; 95% CI: 0.38, 0.82).
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 11 cited sources checked · 0 supported · 0 flagged
- Findingown data
Each 1 serving/d increment in nut consumption is associated with a lower risk of hypertension (RR 0.66; 95% CI 0.44, 1.00; P = 0.049).
“The consumption of each 1 serving of nuts/d was significantly associated with incident CAD (RR: 0.81; 95% CI: 0.72, 0.91; P , 0.001) and hypertension (RR: 0.66; 95% CI: 0.44, 1.00; P = 0.049).”
- Also stated in: § Dose-response analysis · plain
“The summary RR for each 1-serving/d intake was 0.66 (95% CI: 0.44, 1.00; P = 0.049; Figure 4)”
Quote in the paperSubstantial claim - Also stated in: § Dose-response analysis · plain
- Findingown data
Each 1 serving/d increment in nut consumption is not associated with risk of stroke (RR 0.90; 95% CI 0.71, 1.14).
“However, there was no association between the consumption of each 1 serving of nuts/d and risk of stroke (RR: 0.90; 95% CI: 0.71, 1.14)”
- Also stated in: § Dose-response analysis · plain
“There was no significant association between higher nut consumption and risk of stroke [RR: 0.90 (95% CI: 0.71, 1.14) for each 1-serving/d consumption, Figure 3)”
Quote in the paperSubstantial claim - Also stated in: § Dose-response analysis · plain
- Findingown data
Each 1 serving/d increment in nut consumption is not associated with risk of type 2 diabetes (T2D) (RR 0.80; 95% CI 0.57, 1.14).
“or T2D (RR: 0.80; 95% CI: 0.57, 1.14)”
- Also stated in: § Dose-response analysis · plain
“There was no significant association between higher nut consumption and risk of T2D (for each 1-serving/d consumption: RR: 0.80 (95% CI: 0.57, 1.14); P = 0.217; Figure 5)”
Quote in the paperSubstantial claim - Also stated in: § Dose-response analysis · plain
- Findingown data
There is no curvilinear association between nut consumption and risk of T2D (P-nonlinearity > 0.05).
“We showed no evidence of a curvelinear association between nut consumption and risk of T2D (P-nonlinearity .0.05).”
Quote in the paperNot a substantial claim - Findingown data
There is no curvilinear association between nut consumption and risk of CAD (P-nonlinearity > 0.05).
“We did not find a curvelinear association between nut consumption and risk of CAD (P-nonlinearity .0.05).”
Quote in the paperNot a substantial claim
- Findingown data
There is no curvilinear association between nut consumption and risk of hypertension (P-nonlinearity > 0.05).
“We showed no evidence of a curvelinear association between nut consumption and risk of hypertension (P-nonlinearity .0.05).”
Quote in the paperNot a substantial claim - Findingown data
Each 1 serving/d increment in nut consumption is associated with a lower risk of incident coronary artery disease (CAD) (RR 0.81; 95% CI 0.72, 0.91; P < 0.001).
“The consumption of each 1 serving of nuts/d was significantly associated with incident CAD (RR: 0.81; 95% CI: 0.72, 0.91; P , 0.001)”
- Also stated in: § Dose-response analysis · plain
“The summary RR for each 1-serving/d intake was 0.81 (95% CI: 0.72, 0.91; P , 0.001; Figure 2)”
Quote in the paperSubstantial claim - Also stated in: § Dose-response analysis · plain
- Findingown data
Highest compared with lowest nut intake is associated with lower risk of CAD (RR 0.83; 95% CI 0.74, 0.93).
“The highest intake of nuts was inversely associated with risk of CAD (RR: 0.83; 95% CI: 0.74, 0.93; see Supplemental Figure 1 under”
Quote in the paperSubstantial claim - Findingown data
Highest compared with lowest nut intake is associated with lower risk of hypertension (RR 0.85; 95% CI 0.79, 0.92).
“The highest intake of nuts was inversely associated with risk of hypertension (RR: 0.85; 95% CI: 0.79, 0.92; see Supplemental Figure 3 under”
Quote in the paperSubstantial claim - Findingown data
Highest compared with lowest nut intake is not associated with risk of stroke (RR 0.87; 95% CI 0.74, 1.03).
“There was no association between nut intake and risk of stroke (highest compared with lowest categories: RR, 0.87; 95% CI, 0.74, 1.03; see Supplemental Figure 2 under”
Quote in the paperSubstantial claim - Findingown data
Highest compared with lowest nut intake is not associated with risk of T2D (RR 0.92; 95% CI 0.78, 1.09).
“The highest intake of nuts was not associated with risk of T2D (RR: 0.92; 95% CI: 0.78, 1.09; see Supplemental Figure 4 under”
Quote in the paperSubstantial claim - Findingown data
There is no curvilinear association between nut consumption and risk of stroke (P-nonlinearity > 0.05).
“We showed no evidence of a curvelinear association between nut consumption and risk of stroke (P-nonlinearity .0.05).”
Quote in the paperNot a substantial claim - Study design and conductreasoning
The effect of unmeasured or residual confounding on the observed findings could not be ruled out because of the observational nature of the cohort studies.
“First, because of the observational nature of the cohort study, the effect of unmeasured or residual confounding on the observed findings could not be ruled out.”
Quote in the paperSubstantial claim - Study design and conductown data
There was modest evidence of between-study heterogeneity for CAD.
“with modest evidence of heterogeneity (I 2 = 59.9%,P = 0.010)”
- Also stated in: § Dose-response analysis · plain
“with modest evidence of heterogeneity (I 2 = 56.8%,P = 0.018)”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductown data
There was evidence of between-study heterogeneity for the dose-response analysis of hypertension.
“with evidence of heterogeneity (I 2 = 75.9%,P = 0.006)”
Quote in the paperNot a substantial claim - Study design and conductown data
There was high/significant evidence of between-study heterogeneity for T2D.
“with high evidence of heterogeneity (I 2 = 78.7%,P , 0.001)”
- Also stated in: § Dose-response analysis · plain
“with significant evidence of heterogeneity (I 2 = 87.1%,P , 0.001)”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductown data
No evidence of publication bias was detected for the T2D analyses.
“There was no evidence of a publication bias (Begg's test: P = 1.000,Egger's test: P = 0.806).”
- Also stated in: § Dose-response analysis · plain
“No publication bias was detected by using Begg's (P = 0.707) or Egger's (P = 0.697) test.”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Premisecitation
Results of prospective cohort studies on the association between nut consumption and risk of CAD have been inconsistent.
“However, results have been inconsistent (3)(4)(5)(6)(7)(8)(9).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [3] Key, 1996, Dietary habits and mortality in 11,000 vegetarians and health conscious people: results of a 17 year follow up, BMJ source
Not checked in the free run.
- cites [4] Albert, 2002, Nut consumption and decreased risk of sudden cardiac death in the Physicians’ Health Study, Arch Intern Med source
Not checked in the free run.
- cites [5] Trichopoulou, 2005, Mediterranean diet and survival among patients with coronary heart disease in Greece, Arch Intern Med source
Not checked in the free run.
- Study design and conductown data
No evidence of publication bias was detected for the stroke analyses.
“There was no evidence of a publication bias (Begg's test: P = 0.734; Egger's test: P = 0.550).”
- Also stated in: § Dose-response analysis · plain
“No publication bias was detected by using Begg's (P = 0.308) or Egger's (P = 0.273) test.”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductown data
No evidence of publication bias was detected for the CAD analyses.
“There was no evidence of a publication bias (Begg's test: P = 0.076; Egger's test: P = 0.142).”
- Also stated in: § Dose-response analysis · plain
“No publication bias was detected by using Begg's (P = 0.251) or Egger's (P = 0.141) test.”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductown data
The null association between nut consumption and stroke could not be attributed to lack of statistical power.
“For stroke, although only 4 cohort studies were identified, the numbers of participants and incident stroke cases were 182,730 and 5669, respectively.Therefore, the null significant association of nut consumption with risk of stroke could not be attributed to the statistical power”
Quote in the paperSubstantial claim - Study design and conductown data
Sensitivity analysis excluding one study at a time showed that the inverse association between nut consumption and CAD remained.
“After the sensitivity analysis, RRs (95% CIs) ranged from 0.86 (0.77, 0.96) to 0.81 (0.71, 0.91).”
- Also stated in: § Dose-response analysis · plain
“Summary RRs (95% CIs) ranged from 0.84 (0.74, 0.94) to 0.78 (0.69, 0.89).”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductown data
There was little to modest evidence of between-study heterogeneity for stroke.
“with no evidence of heterogeneity (I 2 = 15.0%,P = 0.317)”
- Also stated in: § Dose-response analysis · plain
“with modest evidence of heterogeneity (I 2 = 49.6%,P = 0.114)”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Study design and conductreasoning
The long duration of follow-up, high follow-up rate, and large number of participants in included studies provided sufficient power to detect the association.
“The main strength of the current study was that the long duration of follow-up, high follow-up rate, and large number of participants in included studies provided sufficient power to detect the association.”
Quote in the paperSubstantial claim - Study design and conductown data
Sensitivity analysis excluding one study at a time showed that the inverse association between nut consumption and hypertension remained.
“After the sensitivity analysis, RRs (95% CIs) ranged from 0.86 (0.79, 0.94) to 0.84 (0.76, 0.93).”
- Also stated in: § Comparison with other studies · hedged
“However, after the exclusion of the study in the sensitivity analysis, the inverse association remained, which suggested the stability of the result.”
Quote in the paperNot a substantial claim - Also stated in: § Comparison with other studies · hedged
- Study design and conductown data
No evidence of publication bias was detected for the hypertension analyses.
“There was no evidence of a publication bias (Begg's test: P = 0.734; Egger's test: P = 0.537).”
- Also stated in: § Dose-response analysis · plain
“No publication bias was detected by using Begg's (P = 0.734) or Egger's (P = 0.195) test.”
Quote in the paperNot a substantial claim - Also stated in: § Dose-response analysis · plain
- Premisecitation
A recent meta-analysis assessing nut consumption with hypertension and T2D was retracted.
“Although one recent meta-analysis assessed the association of nut consumption with risk of hypertension and T2D (23), the article was later retracted by the authors, and readers cannot access the full text of the related results again.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [23] Guo K, Jiang Y, Zhou Z, Li Y. RETRACTED: Nut consumption with risk of hypertension and type 2 diabetes mellitus: a meta-analysis of prospective cohort studies. Eur J Prev Cardiol (Epub ahead of print 30 August 2013). source
Not checked in the free run.
- Premisecitation
Two of the 4 cohort studies in the previous meta-analysis have updated their data with a longer duration of follow-up and more incident cases.
“However, 2 of the included 4 cohort studies have updated the data with a longer duration of follow-up and more incident cases for each study (6,7).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [6] Blomhoff, 2006, Health benefits of nuts: potential role of antioxidants, Br J Nutr source
Not checked in the free run.
- cites [7] Li, 2009, Regular consumption of nuts is associated with a lower risk of cardiovascular disease in women with type 2 diabetes, J Nutr source
Not checked in the free run.
- Premisecitation
Several additional large cohort studies on nut consumption and CAD risk have been published.
“Furthermore, several additional, large cohort studies have been published on nut consumption and CAD risk (5,8,9).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [5] Trichopoulou, 2005, Mediterranean diet and survival among patients with coronary heart disease in Greece, Arch Intern Med source
Not checked in the free run.
- cites [8] Bernstein, 2010, Major dietary protein sources and risk of coronary heart disease in women, Circulation source
Not checked in the free run.
- cites [9] Dilis, 2012, Mediterranean diet and CHD: the Greek European Prospective Investigation into Cancer and Nutrition cohort, Br J Nutr source
Not checked in the free run.
- Premisereasoning
A sufficient statistical power has been achieved to further clarify the association between nut consumption and CAD risk.
“Thus, a sufficient statistical power has been achieved to further clarify the association.”
Quote in the paperSubstantial claim
- Classified as probably not a substantial claim. 5
- May combine two claims. 6
- The quote only partly states this claim. 1
Probably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductcitationThe quality of each included study was assessed using the Newcastle-Ottawa quality scale, a validated scale for nonrandomized studies in meta-analysis.
“The quality of each study was assessed by using the Newcastle-Ottawa quality scale (24), which is a validated scale for nonrandomized studies in a meta-analysis.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [24] Wells GA, Shea B, O’connell D, Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available from: http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (cited 14 October 2013).
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataTwo authors independently assessed articles for compliance with inclusion and exclusion criteria and resolved disagreements through discussion.
“Two authors (BX and SL) independently assessed the articles for compliance with the inclusion and exclusion criteria and resolved disagreements through discussion.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataNot all included studies adjusted for all important covariates (e.g., energy intake, BMI, age), so the combined results should be interpreted with caution.
“Fifth, included studies adjusted for important covariates (see Table S1 under”
Quote in the paperSubstantial claimMay combine two claims.
Study design and conductreasoningBecause most studies used baseline nut consumption as the exposure and some individuals might have changed diet habits during follow-up, misclassification of exposure might have biased the results.
“Third, the majority of studies used the nut consumption at baseline as the dietary exposure.However, during the follow-up period, some individuals might have changed their diet habits.Thus, the misclassification of exposure might have biased the results.”
Quote in the paperNot a substantial claimMay combine two claims. The quote only partly states this claim.
Study design and conductown dataMeta-regression did not identify publication year, subtype endpoint, sex, duration of follow-up, or quality score as the source of heterogeneity for any of the 4 outcomes.
“However, none of these variables were identified as the source of heterogeneity for all 4 outcomes (all P .0.05).”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenNone of the authors had a conflict of interest.
“None of the authors had a conflict of interest.”
Quote in the paperNot a substantial claimMay combine two claims.
Study design and conductown dataMost included studies did not provide data on types of nuts consumed and their preparation, so the influence of types of nuts or preparation methods on outcomes could not be examined.
“Second, most in-cluded studies did not provide data on types of nuts consumed and their preparation including salted, spiced, roasted, or raw nuts.Thus, we are unable to examine the influence of types of nuts or preparation methods on outcomes.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenFunders had no role in the study design, implementation, analysis, and interpretation of data.
“Funders had no role in the study design, implementation, analysis, and interpretation of data.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
PremisecitationA previous meta-analysis of 4 cohort studies suggested an average risk reduction of CAD death by 37% for the highest compared with lowest amounts of nut consumption and a reduction of 8.3% in risk of CAD death for each weekly serving of nuts.
“A previous metaanalysis of 4 cohort studies suggested an average risk reduction of CAD death by 37% for the highest compared with lowest amounts of nut consumption and a reduction of 8.3% in risk of CAD death for each weekly serving of nuts (10).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Kelly, 2006, Nuts and coronary heart disease: an epidemiological perspective, Br J Nutr source
Not checked in the free run.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In observational studies, nuts lower CHD and hypertension risk but not stroke.
“In observational studies, nuts lower CHD (196,212,213) and hypertension risk (213); but not stroke (207, (213).”
From Food Consumption and its Impact on Cardiovascular Disease: Importance of Solutions Focused on the Globalized Food System (2015) · cites this paper as [213]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Steffen study has conflicting publication years
MinorTable 1 lists the Steffen study as published in 2006, but reference 14 gives its publication year as 2005.
“Steffen, 2006 (14)”
“14. Steffen LM, Kroenke CH, Yu X, Pereira MA, Slattery ML, Van Horn L, Gross MD, Jacobs DR Jr. Associations of plant food, dairy product, and meat intakes with 15-y incidence of elevated blood pressure in young black and white adults: the Coronary Artery Risk Development in Young Adults (CARDIA) Study. Am J Clin Nutr 2005;82:1169-77.”
Cites
2 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257 · see citing works
RetractedGuo, K., Jiang, Y., Zhou, Z., & Li, Y. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487313501120 · Cited by 4 · see citing works
RetractedMeasuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · see citing works
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722 · see citing works
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
(2014) · Medical Entomology and Zoology · Cited by 17,633 · see citing works
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955 · see citing works
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689 · cited 1× · see citing works
“A fixed-effects (25) or random-effects (26) model, on the basis of whether there was heterogeneity, was used to calculate pooled RRs with 95% CIs for highest compared with lowest amounts of nuts consumption and the dose-response analysis.”
MethodInflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769 · see citing works
Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353 · see citing works
Generalized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,245 · see citing works
Appel, L. J., Sacks, F. M., Carey, V. J., Obarzanek, E., Swain, J. F., Miller, E. R., Conlin, P. R., Erlinger, T. P., Rosner, B. A., Laranjo, N. M., et al. (2005) · JAMA · doi:10.1001/jama.294.19.2455 · Cited by 1,170 · see citing works
Regression Models in Clinical Studies: Determining Relationships Between Predictors and Response
Harre, F. E., Lee, K. L., & Pollock, B. G. (1988) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/80.15.1198 · Cited by 960 · see citing works
Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet
Salas-Salvadó, J., Bulló, M., Babio, N., Martínez-González, M. Á., Ibarrola-Jurado, N., Basora, J., Estruch, R., Covas, M. I., Corella, D., Arós, F., et al. (2011) · Diabetes Care · doi:10.2337/dc10-1288 · Cited by 901 · see citing works
A Possible Protective Effect of Nut Consumption on Risk of Coronary Heart Disease
Fraser, G. E. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.152.7.1416 · Cited by 730 · see citing works
Fraser, G., Sabaté, J., Beeson, W., & Strahan, T. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400190054010 · Cited by 727 · see citing works
Major Dietary Protein Sources and Risk of Coronary Heart Disease in Women
Bernstein, A. M., Sun, Q., Hu, F. B., Stampfer, M. J., Manson, J. E., & Willett, W. C. (2010) · Circulation · doi:10.1161/circulationaha.109.915165 · Cited by 573 · see citing works
Nut and peanut butter consumption and risk of type 2 diabetes in women
Jiang, R. (2002) · JAMA · doi:10.1001/jama.288.20.2554 · Cited by 489 · see citing works
Health benefits of nuts: potential role of antioxidants
Blomhoff, R., Carlsen, M. H., Andersen, L. F., & Jacobs, D. R. (2006) · British Journal Of Nutrition · doi:10.1017/bjn20061864 · Cited by 430 · see citing works
Nut consumption and decreased risk of sudden cardiac death in the Physicians’ Health Study
Albert, C. M., Gaziano, J. M., Willett, W. C., & Manson, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.12.1382 · Cited by 396 · see citing works
Legume and soy food intake and the incidence of type 2 diabetes in the Shanghai Women's Health Study
Villegas, R., Gao, Y.-T., Yang, G., Li, H.-L., Elasy, T. A., Zheng, W., & Shu, X. O. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.162 · Cited by 393 · see citing works
Steffen, L. M., Kroenke, C. H., Yu, X., Pereira, M. A., Slattery, M. L., Horn, L. V., Gross, M. D., & Jacobs, D. R. (2005) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/82.6.1169 · Cited by 334 · see citing works
Key, T. J. A., Thorogood, M., Appleby, P. N., & Burr, M. L. (1996) · BMJ · doi:10.1136/bmj.313.7060.775 · Cited by 305 · see citing works
Salas-Salvadó, J., Garcia-Arellano, A., Estruch, R., Marquez-Sandoval, F., Corella, D., Fiol, M., Gómez-Gracia, E., Viñoles, E., Arós, F., Herrera, C., et al. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602762 · Cited by 295 · see citing works
Mediterranean diet and survival among patients with coronary heart disease in Greece
Trichopoulou, A., Bamia, C., & Trichopoulos, D. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.8.929 · Cited by 266 · see citing works
Food consumption and the incidence of type II diabetes mellitus
Montonen, J., Järvinen, R., Heliövaara, M., Reunanen, A., Aromaa, A., & Knekt, P. (2005) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602094 · Cited by 237 · see citing works
Dietary protein sources and the risk of stroke in men and women.
Bernstein, A. M., Pan, A., Rexrode, K. M., Stampfer, M., Hu, F. B., Mozaffarian, D., & Willett, W. C. (2012) · Stroke · doi:10.1161/strokeaha.111.633404 · Cited by 203 · see citing works
Nuts and coronary heart disease: an epidemiological perspective
Kelly, J. H., & Sabaté, J. (2006) · British Journal of Nutrition · doi:10.1017/bjn20061865 · Cited by 193 · see citing works
Intake of antioxidant vitamins and risk of death from stroke in postmenopausal women
Yochum, L., Folsom, A. R., & Kushi, L. H. (2000) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/72.2.476 · Cited by 168 · see citing works
Walnut Consumption Is Associated with Lower Risk of Type 2 Diabetes in Women
Pan, A., Sun, Q., Manson, J. E., Willett, W. C., & Hu, F. B. (2013) · Journal of Nutrition · doi:10.3945/jn.112.172171 · Cited by 166 · see citing works
Frequency of nut consumption and mortality risk in the PREDIMED nutrition intervention trial
Guasch‐Ferré, M., Bulló, M., Martínez‐González, M. Á., Ros, E., Corella, D., Estruch, R., Fitó, M., Arós, F., Wärnberǵ, J., Fiol, M., et al. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-164 · Cited by 156 · see citing works
Risk factors for mortality in the Nurses’ Health Study: a competing risks analysis
Baer, H. J., Glynn, R. J., Hu, F. B., Hankinson, S. E., Willett, W. C., Colditz, G. A., Stampfer, M., & Rosner, B. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwq368 · Cited by 153 · see citing works
Li, T. Y., Brennan, A. M., Wedick, N. M., Mantzoros, C., Rifai, N., & Hu, F. B. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103622 · Cited by 143 · see citing works
Nuts and Berries for Heart Health
Ros, E., Tapsell, L. C., & Sabaté, J. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0132-5 · Cited by 130 · see citing works
Nut consumption and risk of hypertension in US male physicians
Djoussé, L., Rudich, T., & Gaziano, J. M. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.08.005 · Cited by 128 · see citing works
Dilis, V., Katsoulis, M., Lagiou, P., Trichopoulos, D., Naska, A., & Trichopoulou, A. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001821 · Cited by 121 · see citing works
Nuts, inflammation and insulin resistance.
Casas‐Agustench, P., Bulló, M., & Salas‐Salvadó, J. (2010) · PubMed · Cited by 74 · see citing works
Nut consumption and risk of type II diabetes in the Physicians' Health Study
Kochar, J., Gaziano, J. M., & Djoussé, L. (2010) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2009.121 · Cited by 65 · see citing works
Weng, L.-C. C., Steffen, L. M., Szklo, M., Nettleton, J. A., Chambless, L. E., & Folsom, A. R. (2013) · Nutrients · doi:10.3390/nu5051719 · Cited by 63 · see citing works
Nut consumption and incidence of hypertension: The SUN prospective cohort
Martínez‐Lapiscina, E. H., Pimenta, A. M., Beunza, J. J., Bes‐Rastrollo, M., Martínez, J. A., & Martínez‐González, M. Á. (2009) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2009.04.013 · Cited by 56 · see citing works
Nut Consumption and Risk of Type 2 Diabetes
Parker, E. D., Harnack, L., & Folsom, A. R. (2003) · JAMA · doi:10.1001/jama.290.1.38 · Cited by 48 · see citing works
Nut Consumption and Risk of Stroke in US Male Physicians
Djoussé, L., Gaziano, J., Kase, C., & Kurth, T. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2010.03.005 · Cited by 36 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Anand, S. S., Hawkes, C., de Souza, R. J., Mente, A., Dehghan, M., Nugent, R., Zulyniak, M. A., Weis, T., Bernstein, A. M., Krauss, R. M., et al. (2015) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2015.07.050 · Cited by 507 · see citing works
“In observational studies, nuts lower CHD (196,212,213) and hypertension risk (213); but not stroke (207,213).”
BackgroundNdanuko, R. N., Tapsell, L. C., Charlton, K. E., Neale, E. P., & Batterham, M. J. (2016) · Advances in Nutrition · doi:10.3945/an.115.009753 · Cited by 403 · see citing works
Mayhew, A. J., de Souza, R. J., Meyre, D., Anand, S. S., & Mente, A. (2016) · British Journal Of Nutrition · doi:10.1017/s0007114515004316 · Cited by 147 · see citing works
Toh, D. W. K., Koh, E. S., & Kim, J. E. (2020) · Nutrition Reviews · doi:10.1093/nutrit/nuz104 · Cited by 33 · see citing works
Retracted systematic reviews continued to be frequently cited: a citation analysis
Wang, Z., Shi, Q., Zhou, Q., Zhao, S., Hou, R., Lu, S., Gao, X., & Chen, Y. (2022) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2022.05.013 · Cited by 13 · see citing works
Retracted
- Authors
- Zhou, D., Yu, H., He, F., Reilly, K. H., Zhang, J., Li, S., Zhang, T., Wang, B., Ding, Y., & Xi, B.
- Affiliations
- Shandong University (CN)
- Venue
- The American Journal of Clinical Nutrition
- Publisher
- Elsevier BV
- Published
- 2014-07
- Volume
- 100
- Issue
- 1
- Pages
- 270-277
- ISSN
- 0002-9165 (ISSN-L)
- OpenAlex
- W2163875227
- Semantic Scholar
- a6f11859e0273e0faba029754dffd6e6096be49c
- Cited by
- 137
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 8 · 2023: 10 · 2022: 16 · 2021: 11 · 2020: 9 · 2019: 10 · 2018: 21 · 2017: 14 · 2016: 7 · 2015: 19 · 2014: 9
- FWCI
- 1.87
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- American Journal of Clinical Nutrition (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81273166)
- Key Projects of Science and Technology Plan Medical and Scientific Research Units of Dongguan (2012105102010)
- Science and Technology Innovation Team Project in Doctor Granting of Guangdong Medical College (STIF201121)
- Science and Technology Innovation Project of Guangdong Province (2013KJCX0089)
- Key Disciplines of Guangdong Medical College Project (GDMCKSF201105)
- NIH (psychoceramics-1152342)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Nuts composition and effects
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Nutritional Studies and Diet
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- nut consumption, cardiovascular risk, coronary artery disease, stroke, hypertension, type 2 diabetes, dietary fat, prospective cohort
- MeSH terms
- Cardiovascular Diseases, Diabetes Mellitus, Type 2, Diet, Humans, Nuts, Risk Factors, Databases, Factual, Risk Reduction Behavior
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-10.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-10.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review